Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Cardiogen

AEDR, H-Ala-Glu-Asp-Arg-OH

Quick Stats
Studies 54
Trials 4
Score 1
2020 pubmed 20 citations

Psychosocial Impact of Predictive Genetic Testing in Hereditary Heart Diseases: The PREDICT Study.

Bordet. Céline C; Brice. Sandrine S; Maupain. Carole C; Gandjbakhch. Estelle E; Isidor. Bertrand B; Palmyre. Aurélien A; Moerman. Alexandre A; Toutain. Annick A; Akloul. Linda L; Brehin. Anne-Claire AC; Sawka. Caroline C; Rooryck-Thambo. Caroline C; Schaefer. Elise E; Nguyen. Karine K; Dupin Deguine. Delphine D; Rouzier. Cécile C; Billy. Gipsy G; Séné. Krystelle K; Denjoy. Isabelle I; Leheup. Bruno B; Planes. Marc M; Mazzella. Jean-Michael JM; Staraci. Stéphanie S; Hebert. Mélanie M; Le Boette. Elsa E; Michon. Claire-Cécile CC; Babonneau. Marie-Lise ML; Curjol. Angélique A; Bekhechi. Amine A; Mansouri. Rafik R; Raji. Ibticem I; Pruny. Jean-François JF; Fressart. Véronique V; Ader. Flavie F; Richard. Pascale P; Tezenas du Montcel. Sophie S; Gargiulo. Marcela M; Charron. Philippe P

Key Findings

  • Anxiety rises significantly between the pre‑test visit and the result disclosure, then returns to baseline shortly after.
  • People with a history of depression or high baseline anxiety are more likely to develop lasting anxiety after testing.
  • Only a small fraction (under 3%) regret having the test, but 12‑19% report adverse effects on professional or family life.

Practical Outcomes

  • For biohackers considering predictive genetic testing, the main takeaway is to prioritize thorough pre‑ and post‑test counseling, especially if you have a history of mood issues. Monitoring mental health after testing is important, as lingering anxiety can affect long‑term well‑being. The findings suggest that the medical benefit isn’t the primary driver for most people, so weigh personal motivations carefully.

Summary

The study looked at how people feel before and after getting genetic test results for inherited heart disease. Anxiety spikes before the test, drops back after the result, but stays a bit higher years later, especially in folks who already had depression or high anxiety. Most people didn't regret testing, but a noticeable minority saw negative changes at work or home.

Abstract

Predictive genetic testing (PGT) is offered to asymptomatic relatives at risk of hereditary heart disease, but the impact of result disclosure has been little studied. We evaluated the psychosocial impacts of PGT in hereditary heart disease, using self-report questionnaires (including the State-Trait Anxiety Inventory) in 517 adults, administered three times to the prospective cohort (PCo: <i>n</i> = 264) and once to the retrospective cohort (RCo: <i>n</i> = 253). The main motivations for undergoing PGT were "to remove doubt" and "for their children". The level of anxiety increased between pre-test and result appointments (<i>p</i> &lt;0.0001), returned to baseline after the result (PCo), and was moderately elevated at 4.4 years (RCo). Subjects with a history of depression or with high baseline anxiety were more likely to develop anxiety after PGT result (<i>p</i> = 0.004 and <i>p</i> &lt;0.0001, respectively), whatever it was. Unfavourable changes in professional and/or family life were observed in 12.4% (PCo) and 18.7% (RCo) of subjects. Few regrets about PGT were expressed (0.8% RCo, 2.3% PCo). Medical benefit was not the main motivation, which emphasises the role of pre/post-test counselling. When PGT was performed by expert teams, the negative impact was modest, but careful management is required in specific categories of subjects, whatever the genetic test result.

Study Information

Provider

pubmed

Year

2020

Date

2020-05-06T00:00:00.000Z

DOI

10.3390/jcm9051365

Citations

20

References

37